Media Coverage header image

Media Coverage

Advanced Search
  • 05252021
    Modern Healthcare

    Quest Diagnostics is working with artificial-intelligence startup Paige to try to identify new biomarkers of cancer and other diseases and develop new software products, the companies said Tuesday. Quest and Paige plan to work together to develop software products that diagnose various cancers based on the biomarkers they discover, for which the companies will seek regulatory approval.

  • 05242021
    Yahoo Finance

    Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years. To help address the health inequity crisis, the Social and Health Research Center (SAHRC) of San Antonio, Texas has developed an evidenced-based program using an innovative digitized curriculum designed to engage children. Quest Diagnostics is collaborating with SAHRC to bring the curriculum to schools and communities where it is most needed.

  • 05142021
    Healio

    The COVID-19 pandemic caused major decreases in hepatitis C virus testing and treatment, hindering efforts to meet WHO goals for 2030, according to a study in the American Journal of Preventive Medicine. “As much as we think about 2020 as the year of the pandemic, it’s also going to be the year that we're going to remember hepatitis C,” Harvey W. Kaufman, MD, senior medical director at Quest Diagnostics and head of Quest Diagnostics health trends research, told Healio.

  • 05092021
    360Dx

    Ginkgo Bioworks this week said it is collaborating with Quest Diagnostics to provide COVID-19 testing for grades K-12 to support in-class learning nationwide. The Boston-based firm noted that Quest can perform 300,000 COVID-19 molecular tests daily through its network of two dozen COVID-19 testing labs, while Ginkgo's Concentric by Ginkgo platform allows schools to sign up for testing, secure data management, order supplies, integrate follow-up testing regimes, and provide support services.

  • 04282021
    Health

    While people might be able to use the terms interchangeably in day-to-day convos, there actually are differences between the terms "disease" and "infection." Technically, a disease is considered an advanced form of an infection, Damian "Pat" Alagia, MD, ob-gyn and the senior medical director for advanced diagnostics and women's health at Quest Diagnostics, tells Health.

  • 04282021
    ROI-NJ

    Quest Diagnostics has extended its QuestDirect COVID-19 Testing Program to small businesses. The program, which was designed to help small businesses foster safer environments for their employees and customers using insights from easy, fast and convenient COVID-19 molecular diagnostic and/or antibody testing services, is now available for wider use.

  • 04252021
    WRTV-TV/ABC

    As the COVID-19 pandemic continues, workers at Quest Diagnostics are sharing what it's been like working on the front lines. Quest is a leader in diagnostic testing throughout the nation and has played a critical role during the pandemic.

  • 04202021
    MedCity News

    Preventive tests fell sharply in the early weeks of the pandemic. Although they've started to rebound, many patients remain undiagnosed or face waits for office visits. To combat this, several insurers sent at-home colon cancer screenings kits to patients who were due for their exam. Last month, Quest Diagnostics rolled out a similar type of at-home screening. The company made its first bet in consumer-directed testing long before the start of the pandemic, when it launched an at-home STD test in 2019.

  • 04082021
    Contemporary OBGYN

    Prescription and illicit drug testing rates declined during the COVID-19 pandemic in 2020, according to a study published in the journal Population Health Management. Harvey W Kaufman, MD, MBA, FCAP, senior medical director, information ventures and office of chief medical officer at Quest Diagnostics conducted the study along with colleagues.

  • 04072021
    PYMNTS.com

    Quest Diagnostics had been preparing for 2020 for two years. As one of the top medical-testing providers in the nation, it first launched its consumer-initiated testing program, QuestDirect, at the end of 2018. Through it, consumers can visit the company's website and order at-home testing kits for 49 different conditions.

  • 04012021
    Fierce Biotech

    Nearly six years after launching a joint venture with IQVIA’s contract research progenitor, Quintiles, Quest Diagnostics is handing over the remainder of its minority share in return for $760 million in cash.

  • 03262021
    South Florida Sun-Sentinel

    Quest Diagnostics is offering $0 out-of-pocket testing. Drive-thru testing is available Monday through Friday, from 9 a.m. to 4 a.m. Partnering with Walmart locations, appointments can be made through Quest Diagnostics’ online portal.

  • 03252021
    Medical Device and Diagnostic Industry

    The COVID-19 pandemic affected diagnostic testing much like it did other parts of the healthcare delivery system — it demanded completely novel approaches at some points, and merely accelerated trends underway at others. In other words, an evolution became a revolution. That revolution, according to Quest Diagnostics Chief Medical Officer Jay Wohlgemuth, MD, can be categorized by just a few words, most notably “convenience.”

  • 03162021
    Yahoo Finance

    Quest Diagnostics recently signed a non-exclusive license agreement with Zora Biosciences Oy, a renowned clinical diagnostics company working to identify robust markers of disease. The agreement is expected to enable Quest Diagnostics in the development of a test service based on Zora's patented ceramide-analysis technology.

  • 03122021
    MedTech Dive

    With the COVID-19 pandemic accelerating interest in telehealth and consumer-initiated testing, Quest Diagnostics is expanding its existing DTC operation to try to capture $250 million of the emerging market.

  • 03122021
    Kansas City Business Journal

    Quest Diagnostics' purchase of some lab operations of a St. Louis-based hospital system will bring a positive result for Lenexa. Quest announced this week that it will acquire the outreach laboratory services business of Mercy.

  • 03112021
    Bloomberg

    Commercial laboratory Quest Diagnostics Inc. sees a growing direct-to-consumer testing opportunity following the Covid-19 pandemic, as patients seek greater control of their health care and the crisis accelerates a shift to digital technologies.

  • 03112021
    Modern Healthcare

    With the acquisition, Quest will pick up the business from 29 Mercy hospital labs and two independent clinic labs servicing patients and providers throughout Arkansas, Kansas, Missouri, and Oklahoma.

  • 03022021
    Fierce Healthcare

    Quest Diagnostics and 98point6 have teamed up to make it easier for patients to connect with a doctor virtually about lab results.

  • 02242021
    Reading Eagle

    Quest Diagnostics introduced a new blood test Wednesday to aid in determining if an individual has developed immunity to the coronavirus by either having had COVID-19 or being vaccinated for it.

  • 02232021
    Fierce Biotech

    Grail has tapped testing giant Quest Diagnostics to help roll out its upcoming multi-cancer blood test, expected to launch in the coming months.

  • 02192021
    News 21 Bronx

    Low-cost rapid COVID-19 testing is now more accessible across the city, thanks to a new testing program being rolled out by the state. It's part of Gov. Cuomo’s New York Forward Rapid Test Program. It will take place at select CVS, Quest Diagnostics and Clarity MedHealth mobile labs across New York City.

  • 02172021
    ROI-NJ

    Quest Diagnostics officials announced this week that its turnaround times for COVID-19 testing are faster than at any other time during the pandemic — with the “vast majority” being turned around in one day.

  • 02162021
    CNN

    Quest Diagnostics said Tuesday it is now sequencing 2,000 tests a week, doubling the amount of genomic sequencing it started performing last month. The company said it is sequencing the tests for the US Centers for Disease Control and Prevention.

  • 02082021
    CNBC

    Steve Rusckowski, Quest Diagnostics CEO, joins ‘Closing Bell’ to discuss coronavirus testing, covid variants, and his outlook on the pandemic as coronavirus cases decrease in the U.S.

Show 5102550100 per page